Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment (SMAART): study protocol for a randomized controlled trial
DiscussionAn efficacy-suggesting SMAART trial could inform the future design of a multi-center, double-blinded, placebo-controlled, parallel-group, randomized controlled trial comparing the clinical efficacy of the polypill strategy for vascular risk moderation among stroke survivors in SSA.Trial registrationClinicalTrials.gov, ID:NCT03329599. Registered on 11 February 2017. (Source: Trials)
Source: Trials - March 14, 2018 Category: Research Source Type: clinical trials
Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas
Condition: Infantile Hemangioma Interventions: Drug: oral propranolol; Drug: oral atenolol Sponsor: Postgraduate Institute of Medical Education and Research Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2017 Category: Research Source Type: clinical trials
